| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/29/2010 | US20100105759 H19 silencing nucleic acid agents for treating rheumatoid arthritis |
| 04/29/2010 | US20100105623 Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs |
| 04/29/2010 | US20100105620 Polypeptides that bind Trail-R1 and Trail-R2 |
| 04/29/2010 | US20100105610 Methods of Inhibiting Tumor Cell Aggressiveness Using the Microenvironment of Human Embryonic Stem Cells |
| 04/29/2010 | US20100105599 Subtilisin variants |
| 04/29/2010 | US20100105573 Vector and microorganism for increasing galactose catabolism and methods therefor |
| 04/29/2010 | US20100105565 Evolved Orthogonal Ribosomes |
| 04/29/2010 | US20100105560 Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (epsps) and herbicide-tolerant plants containing it |
| 04/29/2010 | US20100105141 Sulfonylurea-Responsive Repressor Proteins |
| 04/29/2010 | US20100105140 Plaice dna transposon system |
| 04/29/2010 | US20100105139 Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents |
| 04/29/2010 | US20100105123 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/29/2010 | US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/29/2010 | US20100105114 Methods and Compositions for Regulating Sporulation |
| 04/29/2010 | US20100105110 Method of Adenoviral Vector Synthesis |
| 04/29/2010 | US20100105106 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity |
| 04/29/2010 | US20100105090 Secreted luciferase mluc7 and use thereof |
| 04/29/2010 | US20100105051 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 04/29/2010 | US20100105043 Methods for modulating embryonic stem cell differentiation |
| 04/29/2010 | US20100104662 Composition and methods for modulating cell proliferation and cell death |
| 04/29/2010 | US20100104606 Allergen fragments |
| 04/29/2010 | US20100104600 Methods and Compositions for Increasing Tissue Tropism of Recombinant Adenoviral Vectors |
| 04/29/2010 | US20100104597 N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 04/29/2010 | US20100104592 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/29/2010 | US20100104591 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 04/29/2010 | US20100104577 Methods and materials related to anti-a (beta) antibodies |
| 04/29/2010 | US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
| 04/29/2010 | US20100104573 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104561 TYROSINE-MODIFIED RECOMBINANT rAAV VECTOR COMPOSITIONS AND METHODS FOR USE |
| 04/29/2010 | US20100104560 Botulinum neurotoxin e receptors and uses thereof |
| 04/29/2010 | US20100104556 Epitope-tag for surface-expressed proteins and uses thereof |
| 04/29/2010 | US20100104555 HCV neutralizing epitopes |
| 04/29/2010 | US20100104543 Cellular compositions and methods of making and using them |
| 04/29/2010 | US20100104537 Methods of treating Parkinson's disease using viral vectors |
| 04/29/2010 | US20100104535 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 04/29/2010 | US20100104531 Homogeneous preparations of il-28 and il-29 |
| 04/29/2010 | US20100104530 Anti-vpac1 antibodies and their uses |
| 04/29/2010 | US20100104529 TNF-alpha VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-alpha |
| 04/29/2010 | US20100104508 Human antibodies that bind cxcr4 and uses thereof |
| 04/29/2010 | DE112008001453T5 Pflanzenzellen und Pflanzen mit erhöhter Toleranz und/oder Resistenz gegenüber Umweltstress und erhöhter Biomasseproduktion-KO Plant cells and plants with increased tolerance and / or resistance to environmental stress and increased biomass production-KO |
| 04/29/2010 | CA2741523A1 Human ebola virus species and compositions and methods thereof |
| 04/29/2010 | CA2741399A1 Rab6kifl/kif20a epitope peptide and vaccines containing the same |
| 04/29/2010 | CA2741333A1 Vaccine against african horse sickness virus |
| 04/29/2010 | CA2741285A1 Mutated eif4e sequences from potato which are useful in imparting virus resistance |
| 04/29/2010 | CA2741214A1 Process for preparing inclusion body-forming protein |
| 04/29/2010 | CA2741204A1 Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
| 04/29/2010 | CA2741105A1 A method and apparatus for analysis of a particle |
| 04/29/2010 | CA2740351A1 Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genes |
| 04/29/2010 | CA2740328A1 Multiple exon skipping compositions for dmd |
| 04/29/2010 | CA2740257A1 Plants with increased yield (nue) |
| 04/29/2010 | CA2739895A1 Compositions and methods for inhibiting expression of transthyretin |
| 04/29/2010 | CA2739849A1 Meganuclease recombination system |
| 04/29/2010 | CA2738957A1 Methods for treating eye disorders |
| 04/29/2010 | CA2738105A1 A method for producing a transgenic cell with increased gamma-aminobutyric acid (gaba) content |
| 04/29/2010 | CA2734895A1 Receptor tyrosine kinase assays |
| 04/29/2010 | CA2674454A1 Improved hcv vaccines and methods for using the same |
| 04/28/2010 | EP2180064A2 Multiplex quantification of nucleic acids in diseased cells |
| 04/28/2010 | EP2180063A1 Method of detecting target substance |
| 04/28/2010 | EP2180062A1 Method of detecting target substance |
| 04/28/2010 | EP2180061A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 04/28/2010 | EP2180060A1 Method for produding alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 04/28/2010 | EP2180059A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 04/28/2010 | EP2180058A1 Meganuclease recombination system |
| 04/28/2010 | EP2180057A1 Vector system |
| 04/28/2010 | EP2180056A1 Nucleic acid molecules encoding fatty acid desaturase genes from plants and methods of use |
| 04/28/2010 | EP2180055A1 Rice promoters |
| 04/28/2010 | EP2180054A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 04/28/2010 | EP2180053A2 Wisp polypeptides and therapeutical applications thereof |
| 04/28/2010 | EP2180051A2 Method for detecting and quantifying endogenous wheat DNA sequence |
| 04/28/2010 | EP2180050A2 Cytotoxin-based biological containment |
| 04/28/2010 | EP2180046A1 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms |
| 04/28/2010 | EP2180045A1 Novel protein highly producing recombinant animal cell, method for preparing the same and method for mass-producing protein using the same |
| 04/28/2010 | EP2180044A1 Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity |
| 04/28/2010 | EP2180041A2 New lines of human hepatomas, methods for obtaining same and applications thereof |
| 04/28/2010 | EP2180035A1 Alpha-amylase mutants with altered properties |
| 04/28/2010 | EP2180007A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/28/2010 | EP2179996A1 Sulfonated diarylrhodamine dyes |
| 04/28/2010 | EP2179742A1 Compositions and methods for the treatment of immune related diseases |
| 04/28/2010 | EP2179737A2 Modulating responsiveness to steroids |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP2179643A2 Method of producing double low restorer lines of Brassica napus having a good agronomic value |
| 04/28/2010 | EP2179292A1 Metabolomic profiling of prostate cancer |
| 04/28/2010 | EP2179286A2 Trim24 (tif1a) as p53 modulator and cancer target |
| 04/28/2010 | EP2179045A2 Cartilage-specific expression |
| 04/28/2010 | EP2179043A2 Transgenic plants with increased stress tolerance and yield |
| 04/28/2010 | EP2179042A2 Late blight resistance genes and methods |
| 04/28/2010 | EP2179041A2 Compositions and methods for identification of subspecies characteristics of mycobacterium tuberculosis |
| 04/28/2010 | EP2179040A2 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 04/28/2010 | EP2179039A2 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 04/28/2010 | EP2178944A1 Biodegradable cationic polymer gene transfer compositions and methods of use |
| 04/28/2010 | EP2178901A2 Method for purifying or detecting a target protein |
| 04/28/2010 | EP2178897A1 Nucleic acid sequences for the amplification and detection of respiratory viruses |
| 04/28/2010 | EP2178567A2 Stabilized immune modulatory rna (simra) compounds |
| 04/28/2010 | EP1778867B1 Methods and compositions to detect nucleic acids in a biological sample |
| 04/28/2010 | EP1756286B1 Maize multidrug resistance-associated protein polynucleotides and methods of use |
| 04/28/2010 | EP1694692B1 Formulations and methods for denaturing proteins |
| 04/28/2010 | EP1673450B1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 04/28/2010 | EP1668160B1 Methods, compositions, and kits for the concentration and detection of microorganisms |
| 04/28/2010 | EP1592799B1 Annexin promoter and use in expression of transgenic genes in plants |